首页> 外文期刊>Human Molecular Genetics >Characterization of the mechanisms by which missense mutations in the lysosomal acid lipase gene disrupt enzymatic activity
【24h】

Characterization of the mechanisms by which missense mutations in the lysosomal acid lipase gene disrupt enzymatic activity

机译:溶酶体酸性脂肪酶基因中缺失酶活性的畸变突变的特征

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Hydrolysis of cholesteryl esters and triglycerides in the lysosome is performed by lysosomal acid lipase (LAL). In this study we have investigated how 23 previously identified missense mutations in the LAL gene (LIPA) (OMIM# 613497) affect the structure of the protein and thereby disrupt LAL activity. Moreover, we have performed transfection studies to study intracellular transport of the 23 mutants. Our main finding was that most pathogenic mutations result in defective enzyme activity by affecting the normal folding of LAL. Whereas, most of the mutations leading to reduced stability of the cap domain did not alter intracellular transport, nearly all mutations that affect the stability of the core domain gave rise to a protein that was not efficiently transported from the endoplasmic reticulum (ER) to the Golgi apparatus. As a consequence, ER stress was generated that is assumed to result in ER-associated degradation of the mutant proteins. The two LAL mutants Q85K and S289C were selected to study whether secretion-defective mutants could be rescued from ER-associated degradation by the use of chemical chaperones. Of the five chemical chaperones tested, only the proteasomal inhibitor MG132 markedly increased the amount of mutant LAL secreted. However, essentially no increased enzymatic activity was observed in the media. These data indicate that the use of chemical chaperones to promote the exit of folding-defective LAL mutants from the ER, may not have a great therapeutic potential as long as these mutants appear to remain enzymatically inactive.
机译:溶酶体中胆囊甾酯和甘油三酯的水解由溶酶酸脂肪酶(LAL)进行。在这项研究中,我们研究了LAL基因(LIPA)(OMIM#613497)中鉴定了23例鉴定的畸形突变,影响蛋白质的结构,从而破坏LAL活性。此外,我们已经进行了转染研究以研究23个突变体的细胞内传输。我们的主要发现是,最致病性突变通过影响LAL的正常折叠而导致酶活性有缺陷。然而,导致帽结构域的稳定性降低的大部分突变没有改变细胞内转运,几乎所有影响核心结构域的稳定性的突变都会产生从内质网(ER)的内质网(ER)上没有有效地运输的蛋白质高尔基体。因此,产生ER应激,以导致突变蛋白的ER相关降解。选择两个LAL突变体Q85K和S289C以研究分泌缺陷突变体是否可以通过使用化学伴侣从ER相关的降解中抵消。在测试的五个化学伴侣中,只有蛋白酶抑制剂Mg132显着增加了分泌的突变体LAL的量。然而,在培养基中基本上没有观察到酶活性增加。这些数据表明,只要这些突变体似乎保持酶活性失活,就可以使用化学伴侣来促进来自ER的折叠缺陷的LAL突变体的出口可能没有很大的治疗潜力。

著录项

  • 来源
    《Human Molecular Genetics》 |2019年第18期|共10页
  • 作者单位

    Oslo Univ Hosp Dept Med Genet Unit Cardiac &

    Cardiovasc Genet NO-0424 Oslo Norway;

    Oslo Univ Hosp Dept Microbiol Oslo Norway;

    Oslo Univ Hosp Dept Med Genet Unit Cardiac &

    Cardiovasc Genet NO-0424 Oslo Norway;

    Oslo Univ Hosp Dept Med Genet Unit Cardiac &

    Cardiovasc Genet NO-0424 Oslo Norway;

    Oslo Univ Hosp Dept Med Genet Unit Cardiac &

    Cardiovasc Genet NO-0424 Oslo Norway;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医学遗传学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号